BSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/03/2026 15:41
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization908,013 mln
Float268 mln
Earnings Date08/04/2026
EPS
58.89
Exceptional
P / E
27.51
Elevated
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.36
Borderline
Relative Strength
90
/ 100
Top performer
Debt / Equity
0.21
Very low leverage
Business Description
Founded in 1986 and based in Hyderabad, India, Aurobindo Pharma is a global medicine maker that produces and sells a wide range of generic drugs, active pharmaceutical ingredients, and injectable treatments. The company serves patients across many health conditions, including heart disease, diabetes, cancer, HIV, and respiratory illnesses, among others. Its products reach customers across the United States, Europe, and many other markets worldwide.
